Subscribe to the Voices in Health Care Value newsletter to be notified about new research, policies, and upcoming events relevant to the health care value community.
Welcome to the sixth issue of Voices in Health Care Value, the newsletter of the Research Consortium for Health Care Value Assessment (RC-HCVA). This issue features work from our colleagues at the Innovation and Value Initiative. We appreciate your comments and inputs to subsequent issues. If you are interested in becoming a Colleague in Value (individuals and groups who work in this area or who are simply interested in its findings) please register here.
By George Miller and Beth Beaudin-Seiler
One of the objectives of the Research Consortium for Health Care Value Assessment (RC-HCVA) is to disseminate the work of the consortium and that of our Colleagues in Value for use by other researchers and practitioners interested in these findings. (This newsletter is one of the vehicles we use for that purpose.) In November of this year, RC-HCVA team members presented some of our work at two conferences that addressed issues in value assessment.
The ISPOR Europe 2019 conference, held November 2-6 in Copenhagen, Denmark, convened over 5500 global healthcare stakeholders and thought leaders. Representing more than 90 countries, participants included researchers, academicians, assessors and regulators, payers and policymakers, representatives from the life sciences industry, health care providers and patient engagement organizations. RC-HCVA was there, in an educational panel session entitled “Go Where the Money Is” – Capturing Value Across the Health Care System. The panel, made up of U.S. and U.K. experts, discussed focusing on value in the health care system. Dr. Beth Beaudin-Seiler from the RC-HCVA discussed what is contributing to the rising health care costs in the United States, and how robust measurement strategies can help focus our attention and resources. Dr. William Padula from USC discussed how these different strategies can be used in discussions with various stakeholders in order to resonate and drive change. Finally, Adrian Towse from the Office of Health Economics in London offered a look at what has been the focus of measurement strategies in the U.K. (noting the current emphasis on the value of pharmaceutical services), and where further focus should be placed. The attendance of the ISPOR Europe conference was the largest to date.
On November 12, the PhRMA Foundation and the National Health Council held a conference in Washington, DC on The Next Generation of Value Assessment: Including the Patient Voice. Among the presentations were three panel discussions that addressed the topic of “Moving Beyond Traditional Approaches to Value Assessment.” In the first panel, representatives of four PhRMA Foundation grant recipients summarized their work in value assessment. In addition to Dr. George Miller, co-director of RC-HCVA, panelists included Dr. Susan dosReis of the Center for Patient-Driven Values in Healthcare Evaluation (PAVE), Dr. Jon Campbell of Pharmaceutical Value (pValue), and Dr. Peter J. Neumann of the Center for Enhanced Value Assessment (CEVA). Subsequent panels reacted to the presentations of the first panel. The second panel included the reactions of other value assessors and emphasized the need for new methods for value assessment. The third panel consisted of stakeholders who discussed how value assessment research translates into practical application in the health care system. A slide deck of all the presentations at the conference can be found here.
Each issue will spotlight work by a Colleague in Value. This issue’s spotlight is on the Lown Institute.
The Lown Institute
The Lown Institute is a non-profit, nonpartisan think tank focusing on health and health care. Our vision is a country where all people have the opportunity to be as healthy as they can be, and we believe a radically better American health system is both needed and possible. Our work centers on four main areas: health care value; health equity; accountability; and healing and the human connection. Led by Dr. Vikas Saini, a clinical cardiologist and former Harvard Medical School faculty, and Shannon Brownlee, an author and university lecturer, the Institute conducts research, convenes experts, and sparks public debate to bridge the gap between existing public policy solutions and the care that Americans want and need. We are known for our unique national conferences, groundbreaking Lancet series on overuse and underuse around the world, and annual Shkreli Awards, named for the infamous “pharma bro,” Martin Shkreli.
In January 2020, the Lown Institute will release an action plan addressing the epidemic of medication overload among older Americans. (Medication overload is often referred to as polypharmacy in the medical literature.) The culmination of a two-year project identifying the scope and drivers of medication overload and solutions to it, the plan highlights five key reforms:
Later in 2020, the Institute will release the results of a hospital ranking project that examines institutional performance based on patient outcomes as well as several novel metrics, including social impact.
Sign up for Voices in Health Care Value
The Research Consortium for Health Care Value Assessment is a partnership between Altarum and VBID Health, with funding from the PhRMA Foundation as part of its Value Assessment Initiative, established to promote the pursuit of value in health care delivery in the U.S. Follow us at @ValueConsortium.